# BAG3

## Overview
BAG3 is a gene that encodes the BAG cochaperone 3 protein, a multifunctional co-chaperone involved in various cellular processes. The BAG3 protein is characterized by its interaction with heat shock proteins, particularly Hsp70, and plays a crucial role in protein quality control by regulating protein folding, refolding, and degradation. It is involved in selective macroautophagy, which targets misfolded or aggregated proteins for degradation, thus maintaining cellular homeostasis (Stürner2017The; Behl2016Breaking). BAG3 is also essential for the structural integrity of muscle cells, particularly in stabilizing the sarcomere structure, and influences cytoskeleton dynamics, impacting cell motility and structural stability (Marzullo2020The; Behl2016Breaking). Clinically, mutations in the BAG3 gene are linked to conditions such as dilated cardiomyopathy and myofibrillar myopathy, and its overexpression is associated with certain cancers, making it a significant target for therapeutic interventions (Kirk2021Therapeutic; MeisterBroekema2018Myopathy).

## Structure
The BAG3 protein is a 575 amino acid co-chaperone with a molecular mass of 74 kDa, characterized by several distinct domains that facilitate its interaction with various proteins (Lin2021The). The primary structure includes a conserved BAG domain located at the C-terminal end, which interacts with the ATPase domain of heat shock proteins Hsc70/Hsp70, playing a role in suppressing apoptosis (Basu2021In; Rosati2011BAG3:). The protein also contains a WW domain near the N-terminus, two IPV motifs, and a proline-rich PXXP region (Stürner2017The; Lin2021The). The WW domain is involved in interactions with proline-rich repeats, while the PXXP motif interacts with proteins containing SH3 domains, such as phospholipase C gamma and Src (Stürner2017The; Knezevic2015BAG3:).

The secondary structure of BAG3 is predominantly composed of random coils (72.52%), with α-helices (14.43%) and extended strands (8%) also present (Basu2021In). The tertiary structure has been modeled in silico, showing 96.5% of residues in the Ramachandran favored region, indicating conformational integrity (Basu2021In). BAG3 undergoes post-translational modifications, including phosphorylation and ubiquitination, which influence its function (Stürner2017The). The protein is known to exist in different splice variant isoforms, which may have distinct functional roles (Rosati2011BAG3:).

## Function
BAG3 (BAG cochaperone 3) is a multifunctional protein that plays a critical role in maintaining cellular homeostasis in healthy human cells. It functions primarily as a co-chaperone, interacting with heat shock proteins such as Hsp70 to regulate protein folding, refolding, and degradation, which is essential for cellular protein quality control (Stürner2017The; Behl2016Breaking). BAG3 is involved in selective macroautophagy, a process that targets misfolded or aggregated proteins for degradation, thereby preventing the accumulation of potentially toxic protein aggregates (Stürner2017The; Behl2016Breaking).

In muscle cells, BAG3 is crucial for maintaining the integrity of the sarcomere structure, particularly the Z-disks, by stabilizing filamentous actin and interacting with proteins like CapZβ1 (Lin2021The; Behl2016Breaking). It also modulates myocyte contraction and calcium homeostasis through interactions with β1-adrenergic receptors and L-type Ca2+ channels (Stürner2017The; Lin2021The).

BAG3's role extends to cytoskeleton dynamics, where it influences actin folding and organization, impacting cell motility and structural stability (Marzullo2020The). Its anti-apoptotic properties contribute to cell survival under stress conditions, making it a key player in cellular stress response pathways (Stürner2017The).

## Clinical Significance
Mutations in the BAG3 gene are associated with several cardiac and muscular conditions. One of the primary diseases linked to BAG3 mutations is dilated cardiomyopathy (DCM), characterized by the heart's inability to pump blood efficiently, often leading to heart failure. Mutations, particularly deletions or truncations, in BAG3 are common in hereditary forms of DCM and result in reduced BAG3 levels in heart failure patients, even in nonheritable forms of DCM (Kirk2021Therapeutic; Liu2019Advances). BAG3 mutations have an 80% penetrance and are associated with earlier onset and more severe DCM, especially in men (Kirk2021Therapeutic).

BAG3 is also implicated in myofibrillar myopathy (MFM), a progressive muscle disease characterized by protein aggregation and myofibrillar disintegration. Specific mutations, such as BAG3 P209L, lead to severe MFM with symptoms like muscle weakening and heart failure (MeisterBroekema2018Myopathy; Ruparelia2014Zebrafish). These mutations cause a toxic gain-of-function, leading to protein aggregation and interference with autophagy (MeisterBroekema2018Myopathy).

In cancer, BAG3 is overexpressed in several types, including pancreatic ductal adenocarcinoma, where it promotes cell survival and proliferation, correlating with poor outcomes (Kirk2021Therapeutic). BAG3's role in autophagy and apoptosis regulation makes it a potential therapeutic target in both cancer and heart disease (Kirk2021Therapeutic).

## Interactions
BAG3 (BAG cochaperone 3) is involved in numerous protein interactions that influence various cellular processes. It forms a complex with molecular chaperones HSP70 and HSPB8, as well as the ubiquitin ligase STUB1 and HSP40 DNAJB6, facilitating selective macroautophagy (Stürner2017The). BAG3 interacts with the motor protein dynein, essential for microtubule-dependent transport of substrates to the aggresome, with this interaction mediated by the PxxP region of BAG3 and the 14-3-3γ protein (Stürner2017The). 

BAG3 also binds to phospholipase C-gamma (PLC-γ) through its PXXP region, which contains SH3 binding motifs, and this interaction is regulated by epidermal growth factor (EGF) (Doong2000CAIR1BAG3). It interacts with the cytosolic chaperonin TRiC, involved in actin folding, and plays a role in the correct folding of actin and the actin-crosslinking protein filamin (Marzullo2020The). 

BAG3's interaction with HSP70 inhibits the delivery of proteins to the proteasome, impacting apoptosis, and it forms a complex with HSP70 and IKKγ, increasing NF-κB activity (Marzullo2020The). It also competes with BAG1 for binding to HSP70, affecting the proteasome degradation pathway (Rosati2011BAG3:).


## References


[1. (Ruparelia2014Zebrafish) Avnika A. Ruparelia, Viola Oorschot, Raquel Vaz, Georg Ramm, and Robert J. Bryson-Richardson. Zebrafish models of bag3 myofibrillar myopathy suggest a toxic gain of function leading to bag3 insufficiency. Acta Neuropathologica, 128(6):821–833, October 2014. URL: http://dx.doi.org/10.1007/s00401-014-1344-5, doi:10.1007/s00401-014-1344-5. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00401-014-1344-5)

[2. (Basu2021In) Soumya Basu, Aniket Naha, Balaji Veeraraghavan, Sudha Ramaiah, and Anand Anbarasu. In silico structure evaluation of bag3 and elucidating its association with bacterial infections through protein–protein and host‐pathogen interaction analysis. Journal of Cellular Biochemistry, 123(1):115–127, May 2021. URL: http://dx.doi.org/10.1002/jcb.29953, doi:10.1002/jcb.29953. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.29953)

[3. (Knezevic2015BAG3:) Tijana Knezevic, Valerie D. Myers, Jennifer Gordon, Douglas G. Tilley, Thomas E. Sharp, JuFang Wang, Kamel Khalili, Joseph Y. Cheung, and Arthur M. Feldman. Bag3: a new player in the heart failure paradigm. Heart Failure Reviews, 20(4):423–434, April 2015. URL: http://dx.doi.org/10.1007/s10741-015-9487-6, doi:10.1007/s10741-015-9487-6. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10741-015-9487-6)

[4. (Behl2016Breaking) Christian Behl. Breaking bag: the co-chaperone bag3 in health and disease. Trends in Pharmacological Sciences, 37(8):672–688, August 2016. URL: http://dx.doi.org/10.1016/j.tips.2016.04.007, doi:10.1016/j.tips.2016.04.007. This article has 210 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.tips.2016.04.007)

[5. (MeisterBroekema2018Myopathy) Melanie Meister-Broekema, Rebecca Freilich, Chandhuru Jagadeesan, Jennifer N. Rauch, Rocio Bengoechea, William W. Motley, E. F. Elsiena Kuiper, Melania Minoia, Gabriel V. Furtado, Maria A. W. H. van Waarde, Shawn J. Bird, Adriana Rebelo, Stephan Zuchner, Peter Pytel, Steven S. Scherer, Federica F. Morelli, Serena Carra, Conrad C. Weihl, Steven Bergink, Jason E. Gestwicki, and Harm H. Kampinga. Myopathy associated bag3 mutations lead to protein aggregation by stalling hsp70 networks. Nature Communications, December 2018. URL: http://dx.doi.org/10.1038/s41467-018-07718-5, doi:10.1038/s41467-018-07718-5. This article has 68 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-07718-5)

[6. (Liu2019Advances) Leiling Liu, Kaijun Sun, Xiaojun Zhang, Ying Tang, and Danyan Xu. Advances in the role and mechanism of bag3 in dilated cardiomyopathy. Heart Failure Reviews, 26(1):183–194, December 2019. URL: http://dx.doi.org/10.1007/s10741-019-09899-7, doi:10.1007/s10741-019-09899-7. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10741-019-09899-7)

[7. (Lin2021The) Heng Lin, Shon A. Koren, Gregor Cvetojevic, Peter Girardi, and Gail V. W. Johnson. The role of bag3 in health and disease: a “magic bag of tricks”. Journal of Cellular Biochemistry, 123(1):4–21, May 2021. URL: http://dx.doi.org/10.1002/jcb.29952, doi:10.1002/jcb.29952. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.29952)

[8. (Rosati2011BAG3:) A Rosati, V Graziano, V De Laurenzi, M Pascale, and M C Turco. Bag3: a multifaceted protein that regulates major cell pathways. Cell Death &amp; Disease, 2(4):e141–e141, April 2011. URL: http://dx.doi.org/10.1038/cddis.2011.24, doi:10.1038/cddis.2011.24. This article has 253 citations.](https://doi.org/10.1038/cddis.2011.24)

[9. (Doong2000CAIR1BAG3) Howard Doong, John Price, Young Sook Kim, Christopher Gasbarre, Julie Probst, Lance A Liotta, Jay Blanchette, Kathryn Rizzo, and Elise Kohn. Cair-1/bag-3 forms an egf-regulated ternary complex with phospholipase c-γ and hsp70/hsc70. Oncogene, 19(38):4385–4395, September 2000. URL: http://dx.doi.org/10.1038/sj.onc.1203797, doi:10.1038/sj.onc.1203797. This article has 129 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1203797)

[10. (Kirk2021Therapeutic) Jonathan A. Kirk, Joseph Y. Cheung, and Arthur M. Feldman. Therapeutic targeting of bag3: considering its complexity in cancer and heart disease. Journal of Clinical Investigation, August 2021. URL: http://dx.doi.org/10.1172/jci149415, doi:10.1172/jci149415. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci149415)

[11. (Stürner2017The) Elisabeth Stürner and Christian Behl. The role of the multifunctional bag3 protein in cellular protein quality control and in disease. Frontiers in Molecular Neuroscience, June 2017. URL: http://dx.doi.org/10.3389/fnmol.2017.00177, doi:10.3389/fnmol.2017.00177. This article has 153 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2017.00177)

[12. (Marzullo2020The) Liberato Marzullo, Maria Caterina Turco, and Margot De Marco. The multiple activities of bag3 protein: mechanisms. Biochimica et Biophysica Acta (BBA) - General Subjects, 1864(8):129628, August 2020. URL: http://dx.doi.org/10.1016/j.bbagen.2020.129628, doi:10.1016/j.bbagen.2020.129628. This article has 28 citations.](https://doi.org/10.1016/j.bbagen.2020.129628)